Hall Ashley has filed 8 Form 4s with the SEC that we hold, for Structure Therapeutics Inc. (GPCR) (Chief Development Officer) and OnKure Therapeutics, Inc. (RPHM) (Chief Development Officer). Across all of them we count 0 purchases worth $0 and 1 sale worth $98.1K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 15,625 shares of OnKure Therapeutics, Inc. worth $98.1K, dated 2023-08-28. The first filing on our record is dated 2021-11-15 and the latest 2026-03-23.
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-28 | S, sale reported on Form 4 | 15,625 | $98.1K | 2023-08-29 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1801842) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms
No password to create and no card required. We store your email address and nothing else.